Pre-operative coagulopathy management of a neonate with complex congenital heart disease: a case study

Abstract

Severe coagulation defects often develop in neonates undergoing cardiac surgery, both as a result of the surgical intervention, and as pre-existing defects in the hemostatic mechanisms. The following case report describes a newborn patient with complex congenital heart disease and respiratory failure whose pre-operative coagulopathy was aggressively managed prior to surgical correction.

A 5-day-old, 2.5 kg child presented with interrupted aortic arch, ventricular septal defect, atrial septal defect, and patent ductus arteriosus. On admission, he was in respiratory arrest suffering from profound acidemia. In addition, the child was hypothermic (30.1°C), septic (Streptococcus viridans), and coagulopathic (disseminated intravascular coagulation - DIC). The patient was immediately intubated and initial coagulation assessment revealed the following: prothrombin time (PT) 48.9 s (international normalized ratio (INR) 15.7), activated partial thromboplastin time (aPTT) •106 s, platelet count 30 000 mm³, fibrinogen 15 mg dL^-1 and antithrombin III (AT-III) 10%.

Before cardiac surgery could be performed, the patient’s DIC was corrected with the administration of cryoprecipitate (15 ml), fresh frozen plasma (300 ml), and platelets (195 ml). In spite of the large transfusion of fresh frozen plasma, the AT-III activity, measured as a percentage, remained depressed at 33. Initial thromboelastographic (TEG) determination revealed an index of +2.02, and following 100 IU administration of an AT-III concentrate, declined to -2.32. Sequential TEG profiles were performed over several days, with the results used to guide both transfusion and medical therapy. The congenital heart defect correction was subsequently performed with satisfactory initial results, but the patient developed a fungal infection and expired on the 16th post-operative day.

The present case describes techniques of coagulation management for a newborn with both a severe hemostatic defect and congenital heart disease.

Get full access to this article

View all access options for this article.

References

Malviya S. Monitoring and management of anticoagulation in children requiring extracorporeal circulation . Semin Thromb Hemost 1997; 23: 563-567 .

Turner-Gomes SO , Mitchell L , Williams WG , Andrew M. Thrombin regulation in congenital heart disease after cardiopulmonary bypass operations . J Thorac Cardiovasc Surg 1994; 107: 562-568 .

Andrew M , Paes B , Milner R et al. Development of the human coagulation system in the full-term infant . Blood 1987; 70: 165-172 .

Jochum M. Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation . Semin Hematol 1995; 32: 19-32 .

Shapiro A. Antithrombin deficiency in special clinical syndromes - part I. Neonatal and pediatric/physiologic deficiency: extracorporeal membrane oxygenation . Semin Hematol 1995; 32: 33-36 .

Jobe MI. Mechanisms of coagulation and fibrinolysis. In: Stiene-Martin EA , Lotspeich-Steininger CA , Koepke JA eds. Clinical hematology: principles, procedures, correlations, 3rd edn. Philadelphia, PA: Lippincott , 1998: 612-634.

Eberg O. Inherited antithrombin deficiency causing thrombophilia . Thromb Diath Haemorrh 1965; 13: 516-530 .

Bauer KA. In: Ratnoff OD , Forbes CD eds. Disorders of hemostasis, 3rd edn. Philadelphia, PA: WB Saunders , 1996: 228-258.

Thaler E , Lechner K. Antithrombin III deficiency and thromboembolism . Clin Haemotol 1981; 10: 369-390 .

10.

Penner J. Antithrombin deficiency in special clinical syndromes - part II. Trauma/burns . Semin Hematol 1995; 32: 42-47 .

11.

Ambruso DR , Jacobson LJ , Hathway WE. Inherited antithrombin III deficiency and cerebral thrombosis in a child . Pediatrics 1980; 65: 125-131 .

12.

Brenner B , Fishman A , Goldsher D et al. Cerebral thrombosis in a newborn with a congenital deficiency in antithrombin III . Am J Haemotol 1988; 27: 209-211 .

13.

Ens GE. Disorders leading to thrombosis. In: Stiene-Martin EA , Lotspeich-Steininger CA , Koepke JA eds. Clinical hematology: principles, procedures, correlations, 3rd edn. Philadelphia, PA: Lippincott , 1998: 675-681.

14.

Peters M , Jansen E , ten Cate JW et al. Neonatal antithrombin III . Br J Hematol 1984; 58: 579-587 .

15.

Schmidt BK. Antithrombin III deficiency in neonatal respiratory distress syndrome . Blood Coag Fibrin 1994; 5: S13-S17 .

16.

Manco-Johnson MJ. Neonatal antithrombin III deficiency . Am J Med 1989; 87: 495-525 .

17.

Cohn EJ , Strong LE , Hughes WL Jr et al. Preparation and properties of serum and plasma proteins. IV. A system for the separation in fractions of the protein and lipoprotein components of biologic tissues and fluids . J Am Chem Soc 1946; 68: 459-475 .

18.

Maki M , Terao T , Ikenoue T et al. Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics . Gynecol Obstet Invest 1987; 23: 230-240 .

19.

Fourrier F , Chopin C , Huart J et al. Double-blind, placebo controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation . Chest 1993; 104: 882-888 .

20.

van Beek EJ , von der Mohlen MA , ten Cate JW , Brandjes DP , Buller HR. Antithrombin III concentrate in the treatment of DIC: a retrospective follow-up study . Neth J Med 1994; 45: 206-210 .

21.

Wisecarver JL , Haire WD. Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin III concentrate infusion . Thrombos Res 1989; 54: 709-717 .

22.

Kehl HG , Kececioglu D , Vielhaber H et al. Left atrial thrombus in a 10-month-old boy: successful thrombolysis with recombinant tissue type plasminogen activator after open heart surgery . Int Care Med 1996; 22: 968-971 .

23.

Mazzucconi MG , Gugliotta L , Leone G et al. Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukemia patients treated with low dose Eschericia coli L-asparaginase. A GIMEMA study . Blood Coagul Fibrinolysis 1994; 5: 23-28 .

24.

Stammers AH , Bruda NL , Gonano SC , Hartman ST. Point-of-care coagulation monitoring: applications of the thromboelastograph . Anesthesia 1998; 53: 58-59 .

25.

Stammers AH , Deptula JJ , Zavadil DP , Christensen KA , Sydzyik RT. Coagulopathic induced membrane dysfunction during extracorporeal membrane oxygenation . Perfusion 1997; 12: 143-150 .

26.

Zavadil DP , Stammers AH , Willett LD , Deptula JJ , Christensen KA , Sydzyik RT. Hematological abnormalities in neonatal patients treated with ECMO . J Extra-Corp Tech 1998; 30: 83-90 .

27.

Seguin J , Weatherstone K , Nankervis C. Inherited antithrombin III deficiency in the neonate . Arch Pediatr Adolesc Med 1994; 148: 389-393 .

28.

Brangenberg R , Bodensohn M , Burger U. Antithrombin-III substitution in preterm infants: effect on intracranial hemorrhage and coagulation parameters . Biol Neonate 1997; 72: 76-83 .

29.

Levy J. Antithrombin deficiency in special clinical syndromes - part II. Cardiovascular surgery . Semin Hematol 1995; 32: 49-55 .

30.

Urlesberger B , Zobel G , Zenz W et al. Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants . J Pediatr 1996; 129: 264-268 .

31.

Plotz FB , van Oeveren W , Bartlett RH , Wildevuur CRH. Blood activation during neonatal extracorporeal life support (ECLS) . J Thorac Cardiovasc Surg 1993; 105: 823-832 .